{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:53:39Z","timestamp":1790787219052,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T00:00:00Z","timestamp":1318291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s11136-011-0027-0","type":"journal-article","created":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T14:59:46Z","timestamp":1318258786000},"page":"1177-1183","source":"Crossref","is-referenced-by-count":32,"title":["Health-related quality of life changes associated with buprenorphine treatment for opioid dependence"],"prefix":"10.1007","volume":"21","author":[{"given":"Dennis W.","family":"Raisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Garnand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike R.","family":"Sather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupali","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,11]]},"reference":[{"issue":"2","key":"27_CR1","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0376-8716(03)00059-0","volume":"70","author":"W Ling","year":"2003","unstructured":"Ling, W., & Wesson, D. R. (2003). Clinical efficacy of buprenorphine comparisons to methadone and placebo. Drug and Alcohol Dependence, 70(2), S49\u2013S57.","journal-title":"Drug and Alcohol Dependence"},{"issue":"10","key":"27_CR2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","volume":"349","author":"PJ Fudala","year":"2003","unstructured":"Fudala, P. J., Bridge, T. P., Herbert, S., et al. (2003). Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine, 349(10), 949\u2013958.","journal-title":"New England Journal of Medicine"},{"key":"27_CR3","doi-asserted-by":"crossref","unstructured":"Clark, H. W. (2001). A new era in opioid dependency treatment. Recent law allows qualified physicians to provide care in office setting. Postgrad Med, 109(6), 15\u201316, 25.","DOI":"10.3810\/pgm.2001.06.964"},{"key":"27_CR4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1345\/aph.10421","volume":"36","author":"DW Raisch","year":"2002","unstructured":"Raisch, D. W., Fye, C. L., Boardman, K. D., & Sather, M. R. (2002). Opioid dependence treatment, including buprenorphine\/naloxone. Annals of Pharmacotherapy, 36, 312\u2013321.","journal-title":"Annals of Pharmacotherapy"},{"issue":"9","key":"27_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11090","volume":"11","author":"M Connock","year":"2007","unstructured":"Connock, M., Juarez-Garcia, A., Jowett, S., et al. (2007). Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technology Assessment, 11(9), 1\u2013190.","journal-title":"Health Technology Assessment"},{"issue":"9","key":"27_CR6","first-page":"1573","volume":"73","author":"PA Donaher","year":"2006","unstructured":"Donaher, P. A., & Welsh, C. (2006). Managing opioid addiction with buprenorphine. American Family Physician, 73(9), 1573\u20131578.","journal-title":"American Family Physician"},{"issue":"2","key":"27_CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0740-5472(02)00257-X","volume":"23","author":"W Ling","year":"2002","unstructured":"Ling, W., & Smith, D. (2002). Buprenorphine: blending practice and research. J Subst Abuse Treat, 23(2), 87\u201392.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"27_CR8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1300\/J069v26n03_10","volume":"26","author":"M Torrington","year":"2007","unstructured":"Torrington, M., Domier, C. P., Hillhouse, M., & Ling, W. (2007). Buprenorphine 101: treating opioid dependence with buprenorphine in an office-based setting. Journal of Addictive Diseases, 26(3), 93\u201399.","journal-title":"Journal of Addictive Diseases"},{"issue":"12","key":"27_CR9","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1360-0443.2007.01979.x","volume":"102","author":"J Bell","year":"2007","unstructured":"Bell, J., Shanahan, M., Mutch, C., et al. (2007). A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence. Addiction, 102(12), 1899\u20131907.","journal-title":"Addiction"},{"issue":"5","key":"27_CR10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1360-0443.2001.9656834.x","volume":"96","author":"PG Barnett","year":"2001","unstructured":"Barnett, P. G., Rodgers, J. H., & Bloch, D. A. (2001). A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction, 96(5), 683\u2013690.","journal-title":"Addiction"},{"issue":"1","key":"27_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00019053-200523010-00007","volume":"23","author":"AH Harris","year":"2005","unstructured":"Harris, A. H., Gospodarevskaya, E., & Ritter, A. J. (2005). A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting. Pharmacoeconomics, 23(1), 77\u201391.","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"27_CR12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0376-8716(03)00169-8","volume":"71","author":"CM Doran","year":"2003","unstructured":"Doran, C. M., Shanahan, M., Mattick, R. P., Ali, R., White, J., & Bell, J. (2003). Buprenorphine versus methadone maintenance a cost-effectiveness analysis. Drug and Alcohol Dependence, 71(3), 295\u2013302.","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"27_CR13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1360-0443.2003.00352.x","volume":"98","author":"SM Giacomuzzi","year":"2003","unstructured":"Giacomuzzi, S. M., Riemer, Y., Ertl, M., et al. (2003). Buprenorphine versus methadone maintenance treatment in an ambulant setting a health-related quality of life assessment. Addiction, 98(5), 693\u2013702.","journal-title":"Addiction"},{"issue":"1","key":"27_CR14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jsat.2006.11.009","volume":"33","author":"I Maremmani","year":"2007","unstructured":"Maremmani, I., Pani, P. P., Pacini, M., & Perugi, G. (2007). Substance use and quality of life over 12\u00a0months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. J Subst Abuse Treat, 33(1), 91\u201398.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"27_CR15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1081\/ADA-120020517","volume":"29","author":"KW Smith","year":"2003","unstructured":"Smith, K. W., & Larson, M. J. (2003). Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. American Journal of Drug and Alcohol Abuse, 29(2), 323\u2013335.","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"9","key":"27_CR16","first-page":"833","volume":"40","author":"G Vanagas","year":"2004","unstructured":"Vanagas, G., Padaiga, Z., & Subata, E. (2004). Drug addiction maintenance treatment and quality of life measurements. Medicina (Kaunas), 40(9), 833\u2013841.","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"27_CR17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1360-0443.1997.tb02937.x","volume":"92","author":"M Torrens","year":"1997","unstructured":"Torrens, M., San, L., Martinez, A., Castillo, C., Domingo-Salvany, A., & Alonso, J. (1997). Use of the Nottingham health profile for measuring health status of patients in methadone maintenance treatment. Addiction, 92(6), 707\u2013716.","journal-title":"Addiction"},{"issue":"5","key":"27_CR18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/10826089409047404","volume":"29","author":"C Eklund","year":"1994","unstructured":"Eklund, C., Melin, L., Hiltunen, A., & Borg, S. (1994). Detoxification from methadone maintenance treatment in Sweden: long-term outcome and effects on quality of life and life situation. Int J Addict, 29(5), 627\u2013645.","journal-title":"Int J Addict"},{"issue":"3","key":"27_CR19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/10826089309039624","volume":"28","author":"RR Reno","year":"1993","unstructured":"Reno, R. R., & Aiken, L. S. (1993). Life activities and life quality of heroin addicts in and out of methadone treatment. Int J Addict, 28(3), 211\u2013232.","journal-title":"Int J Addict"},{"issue":"2","key":"27_CR20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF03405775","volume":"95","author":"PE Millson","year":"2004","unstructured":"Millson, P. E., Challacombe, L., Villeneuve, P. J., et al. (2004). Self-perceived health among Canadian opiate users: a comparison to the general population and to other chronic disease populations. Canadian Journal of Public Health, 95(2), 99\u2013103.","journal-title":"Canadian Journal of Public Health"},{"key":"27_CR21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.drugalcdep.2004.04.018","volume":"76","author":"DA Calsyn","year":"2004","unstructured":"Calsyn, D. A., Saxon, A. J., Bush, K. R., et al. (2004). The addiction severity index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity. Drug and Alcohol Dependence, 76, 165\u2013171.","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"27_CR22","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0895-4356(98)00103-6","volume":"51","author":"J Brazier","year":"1998","unstructured":"Brazier, J., Usherwood, T., Harper, R., & Thomas, K. (1998). Deriving a preference-based single index from the UK SF-36 Health Survey. Journal of Clinical Epidemiology, 51(11), 1115\u20131128.","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"27_CR23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. J Health Econ, 21(2), 271\u2013292.","journal-title":"J Health Econ"},{"issue":"1","key":"27_CR24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-7525-1-4","volume":"1","author":"SJ Walters","year":"2003","unstructured":"Walters, S. J., & Brazier, J. E. (2003). What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes, 1(1), 4\u20135.","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"27_CR25","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095\u20131108.","journal-title":"Medical Care"},{"issue":"2","key":"27_CR26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005650-200202000-00006","volume":"40","author":"D Feeny","year":"2002","unstructured":"Feeny, D., Furlong, W., Torrance, G. W., et al. (2002). Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40(2), 113\u2013128.","journal-title":"Medical Care"},{"issue":"6","key":"27_CR27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/intqhc\/10.6.509","volume":"10","author":"RM Kaplan","year":"1998","unstructured":"Kaplan, R. M., Ganiats, T. G., Sieber, W. J., & Anderson, J. P. (1998). The quality of well-being scale: Critical similarities and differences with SF-36. International Journal for Quality in Health Care, 10(6), 509\u2013520.","journal-title":"International Journal for Quality in Health Care"},{"issue":"1","key":"27_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drugalcdep.2005.08.005","volume":"82","author":"P Compton","year":"2006","unstructured":"Compton, P., Ling, W., Moody, D., & Chiang, N. (2006). Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine. Drug and Alcohol Dependence, 82(1), 25\u201331.","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"27_CR29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473\u2013483.","journal-title":"Medical Care"},{"issue":"1","key":"27_CR30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","volume":"32","author":"CA McHorney","year":"1994","unstructured":"McHorney, C. A., Ware, J. E., Jr., Lu, J. F., & Sherbourne, C. D. (1994). The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care, 32(1), 40\u201366.","journal-title":"Medical Care"},{"issue":"3","key":"27_CR31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","volume":"31","author":"CA McHorney","year":"1993","unstructured":"McHorney, C. A., Ware, J. E., Jr., & Raczek, A. E. (1993). The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31(3), 247\u2013263.","journal-title":"Medical Care"},{"key":"27_CR32","unstructured":"Ware JE, Snow KK, Kosinksi M, Gandek B. SF-36 Health survey manual and interpretation guide. The Health Institute New England Medical Journal, Boston, 1993)."},{"key":"27_CR33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hec.650","volume":"11","author":"W Hollingworth","year":"2002","unstructured":"Hollingworth, W., Sullivan, S. D., Emerson, S. S., Gray, D. T., & Jarvik, J. G. (2002). The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain. Health Economics, 11, 71\u201385.","journal-title":"Health Economics"},{"key":"27_CR34","doi-asserted-by":"crossref","unstructured":"Sherbourne, C. D., Un\u00fctzer, J., Schoenbaum, M., Duan, N., Lenert, L. A., Sturm, R., et al. (2001). Can utility-weighted health-related quality-of-life estimates capture health effects of quality improvement for depression? Medical Care, 39(11), 1246\u20131259.","DOI":"10.1097\/00005650-200111000-00011"},{"key":"27_CR35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1525-1497.2003.20611.x","volume":"18","author":"JM Pyne","year":"2003","unstructured":"Pyne, J. M., Rost, K. M., Zhang, M., Williams, D. K., Smith, J., & Fortney, J. (2003). Cost-effectiveness of a primary care depression intervention. Journal of General Internal Medicine, 18, 432\u2013441.","journal-title":"Journal of General Internal Medicine"},{"key":"27_CR36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1023\/B:QURE.0000018488.95206.d6","volume":"13","author":"FS Lobo","year":"2004","unstructured":"Lobo, F. S., Gross, C. R., & Matthees, B. J. (2004). Estimation and comparison of derived preference scores from the SF-36 in lung transplant patients. Quality of Life Research, 13, 377\u2013388.","journal-title":"Quality of Life Research"},{"issue":"2","key":"27_CR37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00019053-200017020-00004","volume":"17","author":"C Green","year":"2000","unstructured":"Green, C., Brazier, J., & Deverill, M. (2000). Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics, 17(2), 151\u2013165.","journal-title":"Pharmacoeconomics"},{"issue":"7\u20138","key":"27_CR38","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1345\/aph.19314","volume":"34","author":"DW Raisch","year":"2000","unstructured":"Raisch, D. W. (2000). Understanding quality-adjusted life years and their application to pharmacoeconomic research. Annals of Pharmacotherapy, 34(7\u20138), 906\u2013914.","journal-title":"Annals of Pharmacotherapy"},{"issue":"4","key":"27_CR39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1360-0443.2003.00335.x","volume":"98","author":"RP Mattick","year":"2003","unstructured":"Mattick, R. P., Ali, R., White, J. M., O\u2019Brien, S., Wolk, S., & Danz, C. (2003). Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction, 98(4), 441\u2013452.","journal-title":"Addiction"},{"issue":"11","key":"27_CR40","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1360-0443.2002.00215.x","volume":"97","author":"N Lintzeris","year":"2002","unstructured":"Lintzeris, N., Bell, J., Bammer, G., Jolley, D. J., & Rushworth, L. (2002). A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal. Addiction, 97(11), 1395\u20131404.","journal-title":"Addiction"},{"issue":"4","key":"27_CR41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","volume":"93","author":"W Ling","year":"1998","unstructured":"Ling, W., Charuvastra, C., Collins, J. F., et al. (1998). Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction, 93(4), 475\u2013486.","journal-title":"Addiction"},{"issue":"5","key":"27_CR42","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/00952990701523698","volume":"33","author":"AM Ponizovsky","year":"2007","unstructured":"Ponizovsky, A. M., & Grinshpoon, A. (2007). Quality of life among heroin users on buprenorphine versus methadone maintenance. American Journal of Drug and Alcohol Abuse, 33(5), 631\u2013642.","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"3","key":"27_CR43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pain.2007.03.028","volume":"129","author":"JC Ballantyne","year":"2007","unstructured":"Ballantyne, J. C., & LaForge, K. S. (2007). Opioid dependence and addiction during opioid treatment of chronic pain. Pain, 129(3), 235\u2013255.","journal-title":"Pain"},{"issue":"3","key":"27_CR44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0033-3182(96)71561-X","volume":"37","author":"K Miotto","year":"1996","unstructured":"Miotto, K., Compton, P., Ling, W., & Conolly, M. (1996). Diagnosing addictive disease in chronic pain patients. Psychosomatics, 37(3), 223\u2013235.","journal-title":"Psychosomatics"},{"issue":"4","key":"27_CR45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jpainsymman.2006.05.010","volume":"32","author":"SM Wu","year":"2006","unstructured":"Wu, S. M., Compton, P., Bolus, R., et al. (2006). The addiction behaviors checklist: validation of a new clinician-based measure of inappropriate opioid use in chronic pain. Journal of Pain and Symptom Management, 32(4), 342\u2013351.","journal-title":"Journal of Pain and Symptom Management"},{"issue":"5","key":"27_CR46","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1524-4733.2004.75011.x","volume":"7","author":"HT Hatoum","year":"2004","unstructured":"Hatoum, H. T., Brazier, J. E., & Akhras, K. S. (2004). Comparison of the HUI3 with the SF-36 preference based SF-6D in a clinical trial setting. Value Health, 7(5), 602\u2013609.","journal-title":"Value Health"},{"issue":"9","key":"27_CR47","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/hec.866","volume":"13","author":"J Brazier","year":"2004","unstructured":"Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13(9), 873\u2013884.","journal-title":"Health Economics"},{"issue":"9","key":"27_CR48","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s11136-009-9539-2","volume":"18","author":"MJ Harrison","year":"2009","unstructured":"Harrison, M. J., Davies, L. M., Bansback, N. J., et al. (2009). The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis. Quality of Life Research, 18(9), 1195\u20131205.","journal-title":"Quality of Life Research"},{"issue":"6","key":"27_CR49","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s11136-007-9207-3","volume":"16","author":"D Khanna","year":"2007","unstructured":"Khanna, D., Furst, D. E., Wong, W. K., et al. (2007). Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis. Quality of Life Research, 16(6), 1083\u20131092.","journal-title":"Quality of Life Research"},{"issue":"4","key":"27_CR50","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1524-4733.2007.00311.x","volume":"11","author":"BB Lee","year":"2008","unstructured":"Lee, B. B., King, M. T., Simpson, J. M., et al. (2008). Validity, responsiveness, and minimal important difference for the SF-6D health utility scale in a spinal cord injured population. Value Health, 11(4), 680\u2013688.","journal-title":"Value Health"},{"issue":"1\u20133","key":"27_CR51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.drugalcdep.2007.11.020","volume":"94","author":"D Broz","year":"2008","unstructured":"Broz, D., & Ouellet, L. J. (2008). Racial and ethnic changes in heroin injection in the United States: implications for the HIV\/AIDS epidemic. Drug and Alcohol Dependence, 94(1\u20133), 221\u2013233.","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"27_CR52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0272989X0102100102","volume":"21","author":"X Badia","year":"2001","unstructured":"Badia, X., Roset, M., Herdman, M., & Kind, P. (2001). A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making, 21(1), 7\u201316.","journal-title":"Med Decis Making"},{"issue":"2","key":"27_CR53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/0272989X9901900204","volume":"19","author":"SE Gabriel","year":"1999","unstructured":"Gabriel, S. E., Kneeland, T. S., Melton, L. J., 3rd, Moncur, M. M., Ettinger, B., & Tosteson, A. N. (1999). Health-related quality of life in economic evaluations for osteoporosis: Whose values should we use? Med Decis Making, 19(2), 141\u2013148.","journal-title":"Med Decis Making"},{"issue":"6","key":"27_CR54","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s11136-007-9206-4","volume":"16","author":"IC Huang","year":"2007","unstructured":"Huang, I. C., Willke, R. J., Atkinson, M. J., Lenderking, W. R., Frangakis, C., & Wu, A. W. (2007). US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference? Quality of Life Research, 16(6), 1065\u20131072.","journal-title":"Quality of Life Research"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-011-0027-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11136-011-0027-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-011-0027-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T19:51:03Z","timestamp":1593114663000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11136-011-0027-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,11]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["27"],"URL":"https:\/\/doi.org\/10.1007\/s11136-011-0027-0","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,11]]}}}